Press Release

HIV/AIDS Drugs Market: Company Profiles, Emerging Technologies, Trends, Industry Growth, Segments, Landscape and Demand by Forecast to 2026

HIV/AIDS Drugs Market Global Industry Size, Share, Forecasts Analysis, Company Profiles, Competitive Landscape and Key Regions 2026 Available at Fortune Business Insights

The global HIV/AIDS drugs market is likely to derive growth form the increasing prevalence of the disease across the world. According to a report published by Fortune Business Insights, titled “HIV/AIDS Drugs Market: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 25,314.0 Mn in 2018. Fortune Business Insights has predicted that the market will reach US$ 40,675.0 Mn by 2026, thereby exhibiting a CAGR of 6.1% in the forecast period

List of players leading the Global AIDS Drugs Market include

  • ViiV Healthcare
  • Gilead Sciences
  • Merck Sharp & Dohme
  • Bristol-Myers Squibb Company
  • Janssen Pharmaceuticals
  • Theratechnologies
  • Mylan Pharmaceuticals
  • Genentech
  • AbbVie

Request a Sample Copy of the Global HIV/AIDS Drugs Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hiv-aids-drugs-market-101115

Global HIV Drugs Market Segmentation

By Drug Class

  • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
  • Integrase Inhibitors
  • Combination HIV Medicines
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Geography

  • North America (the USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Rest of the World

HIV DRUGS: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2019-2026

  1. Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  4. Key Insights
    • Epidemiology of HIV/AIDS by Key Countries
    • Overview of Pipeline Analysis
    • Regulatory Scenario by Key Countries
    • Pricing Analysis
    • Key Strategies Employed by Market Leaders in Various Regions
    • Overview of New Product Launches
  5. Global HIV-AIDS Drugs Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Drug Class
      • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
      • Integrase Inhibitors
      • Combination HIV Medicines
      • Others
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Others
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Rest of World

Continued…

 

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close